Ispecimen appoints robert lim as ceo and director

Woburn, massachusetts--(newsfile corp. - december 12, 2024) - ispecimen inc. (nasdaq: ispc) ("ispecimen" or the "company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it has appointed robert lim as ceo and director. mr. lim is the principal and co-founder of de novo law corporation, a vancouver-based law firm specializing in corporate/commercial law and civil litigation.
ISPC Ratings Summary
ISPC Quant Ranking